• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于接受根治性前列腺切除术治疗的局部晚期前列腺癌的包含MRI的预后列线图。

The prognostic nomogram including MRI for locally advanced prostate cancer treated by radical prostatectomy.

作者信息

Wang Yan, Wu Guangyu, Fan Liancheng, Pan Jiahua, Gong Yiming, Fei Xiaochen, Du Xinxing, Zhu Yinjie, Xue Wei

机构信息

Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

Department of Imaging, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

出版信息

Prostate. 2021 Jun;81(8):463-468. doi: 10.1002/pros.24126. Epub 2021 Apr 6.

DOI:10.1002/pros.24126
PMID:33822399
Abstract

OBJECTIVE

To establish the prognostic nomogram for locally advanced prostate cancer (LAPC) patients treated by radical prostatectomy (RP) based on clinical and multiparametric-MRI (mp-MRI) metrics.

METHODS

One hundred and twenty-one patients diagnosed with LAPC were included in this study. They were all examined by mp-MRI within one week before surgery and treated by RP (36 with RP alone, 48 with neoadjuvant hormonal therapy (NHT) and 37 with neoadjuvant chemohormonal therapy (NCHT)). The biochemical progression-free survival (bPFS) was analyzed by Kaplan-Meier method. Univariate and multivariate analysis were used to determine prognostic factors that were related with bPFS. The prognostic nomogram was established by factors that were significant in multivariate analyses.

RESULTS

The median bPFS had significant difference in the subgroup of treatment (RP alone: 2 [0.00-5.04] vs. NHT: 9.3 [6.746-11.854] vs. NCHT: 11.17 [0.000-25.075] months [Log rank p < .001]), the subgroup of hyperintensity within prostate in DWI (negative: 15.97 [11.202-20.731] vs. positive: 5.2 [2.952-7.448] months [Log rank p < .001]) and the subgroup of pelvic lymph node metastasis (negative: 10.2 [8.404-11.996] vs. unilateral: 4.43 [0.000-11.086] vs. Bilateral: 1.83 [0.636~3.031] [Log rank p < .001]). The method of treatment (hazards ratio [HR], 0.566; 95% confidence interval [CI], 0.356-0.899; p = .016), hyperintensity within prostate in DWI (HR, 2.539; 95% CI, 1.349-4.779; p = .004) and the metastasis burden of pelvic lymph node (HR, 2.492; 95% CI, 1.645-3.777; p < .001) were identified as independent predictors with significance in multivariable Cox regression analysis. The nomogram was established based on these three factors.

CONCLUSION

We established a nomogram based on three significant prognosis factors including the neoadjuvant therapeutic schedule, hyperintensity within prostate in DWI and the metastasis burden of pelvic lymph nodes, which were associated with the clinical outcomes in LAPC patients after surgery.

摘要

目的

基于临床和多参数磁共振成像(mp-MRI)指标,为接受根治性前列腺切除术(RP)的局部晚期前列腺癌(LAPC)患者建立预后列线图。

方法

本研究纳入121例诊断为LAPC的患者。他们均在手术前一周内接受mp-MRI检查,并接受RP治疗(36例单纯RP,48例新辅助激素治疗(NHT),37例新辅助化疗联合激素治疗(NCHT))。采用Kaplan-Meier法分析生化无进展生存期(bPFS)。单因素和多因素分析用于确定与bPFS相关的预后因素。通过多因素分析中有显著意义的因素建立预后列线图。

结果

治疗亚组的中位bPFS有显著差异(单纯RP:2[0.00 - 5.04]个月 vs. NHT:9.3[6.746 - 11.854]个月 vs. NCHT:11.17[0.000 - 25.075]个月[Log秩检验p <.001]),DWI序列中前列腺内高信号亚组(阴性:15.97[11.202 - 20.731]个月 vs. 阳性:5.2[2.952 - 7.448]个月[Log秩检验p <.001])以及盆腔淋巴结转移亚组(阴性:10.2[8.404 - 11.996]个月 vs. 单侧:4.43[0.000 - 11.086]个月 vs. 双侧:1.83[0.636 - 3.031]个月[Log秩检验p <.001])。治疗方法(风险比[HR],0.566;95%置信区间[CI],0.356 - 0.899;p = 0.016)、DWI序列中前列腺内高信号(HR,2.539;95%CI,1.349 - 4.779;p = 0.004)以及盆腔淋巴结转移负荷(HR,2.492;95%CI,1.645 - 3.777;p <.001)在多变量Cox回归分析中被确定为具有显著意义的独立预测因素。基于这三个因素建立了列线图。

结论

我们基于新辅助治疗方案、DWI序列中前列腺内高信号以及盆腔淋巴结转移负荷这三个显著的预后因素建立了列线图,这些因素与LAPC患者术后的临床结局相关。

相似文献

1
The prognostic nomogram including MRI for locally advanced prostate cancer treated by radical prostatectomy.用于接受根治性前列腺切除术治疗的局部晚期前列腺癌的包含MRI的预后列线图。
Prostate. 2021 Jun;81(8):463-468. doi: 10.1002/pros.24126. Epub 2021 Apr 6.
2
Neoadjuvant chemohormonal therapy combined with radical prostatectomy and extended PLND for very high risk locally advanced prostate cancer: A retrospective comparative study.新辅助化疗联合根治性前列腺切除术及扩大盆腔淋巴结清扫术治疗极高危局部晚期前列腺癌:一项回顾性比较研究
Urol Oncol. 2019 Dec;37(12):991-998. doi: 10.1016/j.urolonc.2019.07.009. Epub 2019 Aug 27.
3
The prognostic nomogram for PSA-incongruent low-risk prostate cancer treated by radical prostatectomy.前列腺癌根治术治疗PSA不一致性低风险前列腺癌的预后列线图。
Int Urol Nephrol. 2023 Jun;55(6):1447-1452. doi: 10.1007/s11255-023-03560-x. Epub 2023 Apr 5.
4
A Prospective Randomized Trial of Neoadjuvant Chemohormonal Therapy vs Hormonal Therapy in Locally Advanced Prostate Cancer Treated by Radical Prostatectomy.新辅助化疗联合雄激素剥夺治疗对比单纯雄激素剥夺治疗局部进展期前列腺癌根治术后的前瞻性随机临床试验
J Urol. 2024 May;211(5):648-655. doi: 10.1097/JU.0000000000003876. Epub 2024 Apr 9.
5
A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies.一种新的列线图模型,用于识别经 MRI 靶向和系统活检诊断为局限性前列腺癌患者中需要行扩大盆腔淋巴结清扫术的候选者。
Eur Urol. 2019 Mar;75(3):506-514. doi: 10.1016/j.eururo.2018.10.012. Epub 2018 Oct 17.
6
Magnetic resonance imaging-based radiomics nomogram for the evaluation of therapeutic responses to neoadjuvant chemohormonal therapy in high-risk non-metastatic prostate cancer.基于磁共振成像的放射组学列线图用于评估高危非转移性前列腺癌新辅助化疗内分泌治疗的疗效。
Cancer Med. 2024 Jul;13(14):e70001. doi: 10.1002/cam4.70001.
7
Multiparametric Magnetic Resonance Imaging Is an Independent Predictor of Salvage Radiotherapy Outcomes After Radical Prostatectomy.多参数磁共振成像(MRI)是根治性前列腺切除术后挽救性放疗结局的独立预测因素。
Eur Urol. 2018 Jun;73(6):879-887. doi: 10.1016/j.eururo.2017.11.012. Epub 2017 Nov 28.
8
Histological comparison between predictive value of preoperative 3-T multiparametric MRI and Ga-PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer.术前 3-T 多参数 MRI 和 Ga-PSMA PET/CT 扫描对前列腺癌根治性前列腺切除术和盆腔淋巴结清扫术病理结果的预测价值的组织学比较。
BJU Int. 2021 Jan;127(1):71-79. doi: 10.1111/bju.15134. Epub 2020 Sep 7.
9
The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.根治性前列腺切除术后前列腺特异性抗原持续存在对预测淋巴结阳性前列腺癌患者临床进展和癌症特异性死亡率的作用。
Eur Urol. 2016 Jun;69(6):1142-8. doi: 10.1016/j.eururo.2015.12.010. Epub 2015 Dec 31.
10
Significance of micrometastases in pelvic lymph nodes detected by real-time reverse transcriptase polymerase chain reaction in patients with clinically localized prostate cancer undergoing radical prostatectomy after neoadjuvant hormonal therapy.新辅助激素治疗后接受根治性前列腺切除术的临床局限性前列腺癌患者,实时逆转录聚合酶链反应检测盆腔淋巴结微转移的意义。
BJU Int. 2007 Feb;99(2):315-20. doi: 10.1111/j.1464-410X.2006.06622.x. Epub 2006 Nov 28.

引用本文的文献

1
Development and validation of a nomogram for predicting the overall survival of prostate cancer patients: a large population-based cohort study.预测前列腺癌患者总生存期的列线图的开发与验证:一项基于大人群的队列研究
Transl Androl Urol. 2022 Sep;11(9):1325-1335. doi: 10.21037/tau-22-498.
2
Development and Validation of a Prognostic Model for Predicting Overall Survival in Patients With Bladder Cancer: A SEER-Based Study.预测膀胱癌患者总生存期的预后模型的开发与验证:一项基于监测、流行病学和最终结果(SEER)数据库的研究
Front Oncol. 2021 Jun 17;11:692728. doi: 10.3389/fonc.2021.692728. eCollection 2021.